University Of Chicago

We track 3 ClinicalTrials.gov studies led by University Of Chicago. The portfolio skews toward Phase 2 (2 trials).

3 clinical trials sponsored by University Of Chicago.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
67%
Phase 1 1
33%

Trial Status Breakdown

Trials by University Of Chicago

A Phase I/II Study to Investigate the Combination of LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory T-ALL/LBL

NCT06207123 · RECRUITING · Phase 2

Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity

NCT06171152 · SUSPENDED · Phase 1

Low-Dose Tocilizumab for Acute Chest Syndrome in Sickle Cell Disease

NCT05640271 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does University Of Chicago sponsor?

University Of Chicago currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 1.

What conditions does University Of Chicago research?

University Of Chicago conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is University Of Chicago recruiting for clinical trials?

Yes, University Of Chicago currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More